Randomized Trial Shows Promise of Ketogenic Diet for Psychotic Disorders
Randomized Trial Highlights Ketogenic Diet Benefits in Psychotic Disorders A new clinical study published in Schizophrenia Bulletin has provided encouraging evidence that a ketogenic diet may offer meaningful benefits for…
MEDIPOST Doses First U.S. Patient in Phase III Knee Osteoarthritis Trial
MEDIPOST Treats First U.S. Patient in Phase III Trial of Investigational Stem Cell Therapy for Knee Osteoarthritis MEDIPOST Inc., a biotechnology company specializing in the development of allogeneic, umbilical cord…
GE HealthCare and Mayo Clinic Partner to Advance Personalized Cancer Care
GE HealthCare and Mayo Clinic Launch MI-BET Study to Advance Personalized Radioligand Therapy for Advanced Prostate Cancer GE HealthCare and Mayo Clinic have announced the launch of the Molecular Imaging…
Niagen Bioscience Launches Drug Development Program for Rare Diseases
Niagen Bioscience Launches NB4168 Pharmaceutical Program Targeting Rare Genetic Diseases and Accelerated Aging Niagen Bioscience expands its leadership in NAD+ science into pharmaceutical development with NB4168, an investigational oral therapy…
Octave MSDA Test Distinguishes True MS Relapse from Pseudoexacerbation
Octave MSDA Test Proven Effective in Identifying True MS Relapse Octave Bioscience, a commercial-stage precision neurology company focused on advancing personalized care for multiple sclerosis (MS) and other neurodegenerative disorders,…
Leo Cancer Care Raises $65M Series D to Expand Upright Cancer Care Platform
Leo Cancer Care Secures $65 Million Series D Funding to Expand Upright Cancer Imaging and Treatment Platform Leo Cancer Care has announced the successful completion of an oversubscribed $65 million…
U of T, McMaster Launch Life Sciences Venture Fund with Genesys Capital
U of T, McMaster and Genesys Capital Launch Early-Stage Life Sciences Fund A major new venture capital initiative is set to strengthen Ontario’s life sciences ecosystem by providing early-stage funding…
Agilent Expands Altura Portfolio for Biotherapeutic Analysis
Agilent Expands Altura HPLC Portfolio with New SEC and PLRP-S Columns to Advance Biopharmaceutical Analysis Agilent Technologies Inc. has expanded its Altura high-performance liquid chromatography (HPLC) column portfolio with the…
Immunocine Cancer Center Appoints Vita S. Salsman as Executive Director
Immunocine Cancer Center Appoints Vita S. Salsman as Executive Director to Advance Personalized Cancer Immunotherapy Immunocine Cancer Center has announced the appointment of Vita S. Salsman as its new Executive…
Spear Bio to Showcase Alzheimer’s Immunoassays at AAIC 2026
Spear Bio to Showcase Next-Generation Alzheimer’s Biomarker Technologies and Automated SPEAR Platform at AAIC 2026 Spear Bio, a biotechnology company specializing in ultrasensitive protein biomarker detection technologies, has announced that…
Agenus Reports Positive BOT+BAL Survival Data at ESMO GI 2026
Agenus Reports Three-Year Phase 1b Results for Botensilimab Plus Balstilimab Showing Durable Survival in Refractory MSS Metastatic Colorectal Cancer Agenus Inc., a biotechnology company focused on advancing next-generation immuno-oncology therapies,…
Bayer Partners with University of Colorado Anschutz to Advance Clinical Trials
Bayer Forms Strategic Clinical Trials Alliance with University of Colorado Anschutz, UCHealth, and Children’s Hospital Colorado to Accelerate Medical Innovation Bayer has announced the formation of a landmark strategic alliance…